Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HBV Vaccination of Healthy Volunteers to Evaluate the Composition of Germinal Centers
NCT05272735Phase 4Terminated
- Sponsor
- The Rockefeller University
- Start
- Dec 2022
- Primary completion
- Sep 2025
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Hepatitis B vaccine in hepatitis B (HBV), sponsored by The Rockefeller University. Primary endpoint: The Effects of HBV Vaccine on Memory B Cells at 6 months. Started Dec 2022; status: terminated.
02
Drugs
Hepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT05272735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05272735.